Quality control assessment for the serological diagnosis of dengue virus infections

被引:21
作者
Mantke, OD
Lemmer, K
Biel, SS
Groen, J
Schmitz, H
Durand, JP
Zeller, H
Niedrig, M
机构
[1] Robert Koch Inst, D-13353 Berlin, Germany
[2] Erasmus Med Ctr Rotterdam, NL-3000 CA Rotterdam, Netherlands
[3] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany
[4] Inst Med Top, Serv Sante Armees, F-13998 Marseille, France
[5] Inst Pasteur, F-69365 Lyon 7, France
关键词
dengue virus; virus diagnostics; external quality assurance;
D O I
10.1016/S1386-6532(03)00110-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: A major drawback of modern society's rapidly increasing mobility is the ease with which dangerous infections can be imported into Europe. Often these infections are not diagnosed because physicians are not familiar with the symptoms and laboratory tests are not always available in local diagnostic centres. Improving diagnostics is the most important step in detecting and dealing with these pathogens and quality control measures are, therefore, essential tools. Objectives: To assess the diagnosis of imported dengue virus infections in Europe by (1) running a pre-evaluation panel (four serum samples, sent out in 1999) and optimising sample preparation and shipping procedures and (2) initiating an External Quality Assurance (EQA) program (20 serum samples, sent out in 2002). Study design: All serum samples sent out were to be tested for the presence of dengue virus-specific IgM and IgG. For the pre-evaluation panel, four samples were distributed (one sample IgM+/IgG+, one sample IgM-/IgG+, two samples IgM-/IgG-) and for the EQA 20 samples (12 samples IgM+/IgG+, five samples IgM-/IgG+, one sample IgM+/IgG- two samples IgM-/IgG-). 13 laboratories took part in the pre-evaluation panel and 18 laboratories participated in the first EQA run. Results: For the pre-evaluation panel, the participants reported concurrent and correct results for 88% of the IgG-positive samples and for 100% of the IgG-negative samples. The results for the IgM-positive sample were correct in 91% of the reported tests and in 97% of the IgM-negative samples. For the EQA, the participants reported concurrent and correct results for 71% of the IgG-positive samples and 89% of the IgG-negative samples. 58% concurrent and correct results were reported for the IgM-positive samples and 97% for the IgM-negative samples. Conclusions: The results presented here demonstrate the importance of quality measures for imported viral pathogens like dengue viruses and clearly indicate the need for improving the existing test systems. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 8 条
[1]  
GROEN J, 2000, CLIN DIAGN IMMUN, V6, P1
[2]  
Lewis S M, 1995, Ann Ist Super Sanita, V31, P53
[3]   Multicenter quality assessment of PCR methods for detection of enteroviruses [J].
Muir, P ;
Ras, A ;
Klapper, PE ;
Cleator, GM ;
Korn, K ;
Aepinus, C ;
Fomsgaard, A ;
Palmer, P ;
Samuelsson, A ;
Tenorio, A ;
Weissbrich, B ;
van Loon, AM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) :1409-1414
[4]  
MURGUE B, 2002, COMMUNICATION MAY
[5]  
*R KOCH I, 2002, EPIDEMIOLOGISCHES
[6]   A multicentre quality assessment study to monitor the performance of HIV-1 PCR [J].
Schweiger, B ;
Pauli, G ;
Zeichhardt, H ;
Kucherer, C .
JOURNAL OF VIROLOGICAL METHODS, 1997, 67 (01) :45-55
[7]  
Wood W G, 1991, Ann Ist Super Sanita, V27, P495
[8]  
World Health Organization, WHO REP GLOB SURV EP